pyroglutamyl-phenylalanyl-prolinamide has been researched along with Cancer of Pancreas in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akinsanya, KO; Bennet, WM; Bloom, SR; Byfield, PG; Ghatei, MA; Kulkarni, RN; Smith, DM; Wang, RM; Wang, ZL | 1 |
1 other study(ies) available for pyroglutamyl-phenylalanyl-prolinamide and Cancer of Pancreas
| Article | Year |
|---|---|
Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines.
Topics: Amino Acid Sequence; Animals; Cricetinae; Glucose; Humans; Inositol Phosphates; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Male; Molecular Sequence Data; Oligopeptides; Pancreatic Neoplasms; Perfusion; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1995 |